Nanoparticle Therapy Reverses Alzheimer's in Mice
Originally Published 3 months ago — by Nature
The article discusses a novel nanomedicine approach using mid-affinity, multivalent polymersomes targeting LRP1 to restore blood-brain barrier function, enhance amyloid-β clearance, and improve cognitive outcomes in Alzheimer's disease models, highlighting a shift from transport to repair strategies.